TRANSCAN, the ERA-NET: Aligning national/regional translational cancer research programmes and activities, announced its 4th Joint Transnational Call for Proposals “Translational research on rare cancers”.
EU-OPENSCREEN warmly welcomes consortia bidding for the TRANSCAN call to come and discuss how our respective organisations might cooperate. Please email us at firstname.lastname@example.org for more information.
The transnational research proposals must cover at least one of the following aims:
• Aim 1: Design and conduct of translational research studies exploiting/combining resources from current clinical trials, bio-repositories and epidemiology-type resources.
• Aim 2: Development and exploitation of translational research platforms (e.g., patient derived xenograft models/organoids/tissue collections) to study drug responses/resistance and toxicity, and perform drug screens or repurpose approved anticancer drugs.
• Aim 3: Implementation of precision biomarkers for better stratification of the clinical cohorts.
For detailed information about TRANSCAN’s 4th call, please visit: http://www.transcanfp7.eu/images/documents/CALLS/JTC_2017/TRANSCAN-2_Call_text_JTC_2017_rev_11_12_2017.pdf
For information on TRANSCAN, please visit http://www.transcanfp7.eu